0,774  0,005  CYP1A2 substrate
0,680  0,003  Tyrosine 3 hydroxylase inhibitor
0,680  0,008  5 Hydroxytryptamine release stimulant
0,650  0,004  GABA C receptor rho-3 antagonist
0,650  0,005  Psychostimulant
0,626  0,011  CYP2D6 substrate
0,634  0,032  Caspase 9 stimulant
0,572  0,009  Calcium channel L-type activator
0,560  0,030  15-Lipoxygenase inhibitor
0,524  0,010  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,525  0,011  Dyrk kinase inhibitor
0,427  0,005  Alpha 2b adrenoreceptor antagonist
0,464  0,050  Antiparkinsonian
0,403  0,003  GABA C receptor rho-2 antagonist
0,400  0,009  MAO A inhibitor
0,369  0,014  Male reproductive disfunction treatment
0,374  0,021  Cyclic AMP phosphodiesterase inhibitor
0,383  0,049  Aldehyde oxidase inhibitor
0,363  0,030  Vasodilator
0,384  0,054  Bone diseases treatment
0,395  0,078  Histamine release inhibitor
0,320  0,005  Alpha 2c adrenoreceptor antagonist
0,318  0,006  Alpha 2a adrenoreceptor antagonist
0,356  0,046  Calcium channel activator
0,313  0,004  GABA C receptor antagonist
0,354  0,048  Antiosteoporotic
0,342  0,040  FMO3 substrate
0,353  0,052  Spasmolytic
0,358  0,063  Mood disorders treatment
0,351  0,059  Antidepressant
0,310  0,019  MAO inhibitor
0,290  0,004  5 Hydroxytryptamine 5A antagonist
0,392  0,108  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,396  0,115  Apoptosis agonist
0,277  0,007  VEGF expression inhibitor
0,274  0,004  GABA C receptor rho-1 antagonist
0,344  0,075  Antiprotozoal (Plasmodium)
0,264  0,004  5 Hydroxytryptamine 5 antagonist
0,343  0,086  Ulceration
0,312  0,056  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,336  0,081  Transcription factor NF kappa B inhibitor
0,288  0,034  Antihypotensive
0,280  0,029  Pneumotoxic
0,303  0,059  Antihypoxic
0,251  0,016  SULT1A3 substrate
0,247  0,013  5 Hydroxytryptamine 2C antagonist
0,244  0,012  Alpha 2 adrenoreceptor antagonist
0,289  0,058  Tumour necrosis factor alpha release inhibitor
0,250  0,019  Age-related macular degeneration treatment
0,315  0,089  Vasodilator, peripheral
0,250  0,024  Erectile dysfunction treatment
0,247  0,028  Antiparkinsonian, tremor relieving
0,235  0,017  Death-associated protein kinase 2 inhibitor
0,225  0,008  Antineoplastic alkaloid
0,221  0,005  Phosphodiesterase V inhibitor
0,322  0,108  Antiprotozoal
0,218  0,005  Phosphodiesterase 5A inhibitor
0,218  0,004  Phosphodiesterase XI inhibitor
0,218  0,004  Phosphodiesterase 11A inhibitor
0,220  0,009  MAP3K9 inhibitor
0,281  0,070  UGT2B4 substrate
0,246  0,038  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,274  0,067  Flavin-containing monooxygenase substrate
0,286  0,080  CYP2D6 inhibitor
0,245  0,041  Neurotrophic factor enhancer
0,295  0,101  Antineoplastic (lung cancer)
0,220  0,029  Phosphodiesterase inhibitor
0,259  0,068  Antiprotozoal (Leishmania)
0,259  0,068  Cardiovascular analeptic
0,306  0,116  Antineoplastic (breast cancer)
0,239  0,050  Peroxidase inhibitor
0,204  0,018  SULT1A1 substrate
0,319  0,144  5 Hydroxytryptamine release inhibitor
0,261  0,086  Radioprotector
0,190  0,018  Carbonic anhydrase III inhibitor
0,237  0,065  Cytotoxic
0,195  0,024  Interleukin 4 antagonist
0,229  0,058  Sedative
0,194  0,024  Cyclin-dependent kinase 5 inhibitor
0,277  0,109  Antineoplastic (endocrine cancer)
0,247  0,080  Antineoplastic (renal cancer)
0,185  0,019  Sulfotransferase substrate
0,262  0,097  Antineoplastic (colorectal cancer)
0,215  0,052  Sepsis treatment
0,272  0,110  Antineoplastic (small cell lung cancer)
0,253  0,093  Antineoplastic (colon cancer)
0,163  0,010  Female sexual dysfunction treatment
0,233  0,080  DNA synthesis inhibitor
0,171  0,019  TRPA1 agonist
0,213  0,064  Platelet adhesion inhibitor
0,234  0,086  Superoxide dismutase inhibitor
0,212  0,064  UDP-glucuronosyltransferase substrate
0,241  0,094  Radiosensitizer
0,291  0,144  MAP kinase kinase 6 inhibitor
0,237  0,091  Antioxidant
0,178  0,033  DNA intercalator
0,157  0,012  Cyclin B3 inhibitor
0,248  0,104  Anxiolytic
0,240  0,096  CYP1A2 inhibitor
0,155  0,013  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,160  0,020  Androgen antagonist
0,232  0,095  5 Hydroxytryptamine 1E antagonist
0,202  0,067  Mutagenic
0,171  0,038  5 Hydroxytryptamine 2 antagonist
0,175  0,043  Antifungal enhancer
0,149  0,018  5 Hydroxytryptamine 7 antagonist
0,153  0,023  Creatine kinase inhibitor
0,249  0,119  Antineoplastic (brain cancer)
0,143  0,018  SULT1E1 substrate
0,164  0,040  MAP kinase kinase 4 inhibitor
0,212  0,088  Free radical scavenger
0,259  0,136  Stroke treatment
0,224  0,101  UGT1A9 substrate
0,146  0,025  Estrogen antagonist
0,228  0,107  CYP2C19 substrate
0,255  0,136  Inflammatory Bowel disease treatment
0,202  0,084  Antialcoholic
0,156  0,039  Topoisomerase I inhibitor
0,125  0,011  Narcotic antagonist
0,122  0,008  NMDA receptor subunit 3B antagonist
0,131  0,018  Dopamine agonist
0,117  0,005  MAP kinase kinase 7 inhibitor
0,142  0,030  5 Hydroxytryptamine 2A antagonist
0,139  0,029  HIV-1 integrase (Overall Integration) inhibitor
0,194  0,084  Pyruvate kinase inhibitor
0,132  0,022  Estrogen receptor beta antagonist
0,112  0,002  Imidazoline I1 receptor antagonist
0,133  0,024  Porphobilinogen synthase inhibitor
0,168  0,060  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,198  0,096  UGT1A6 substrate
0,125  0,023  MAP-kinase-activated kinase inhibitor
0,219  0,118  Ca2+/calmodulin-dependent kinase IV inhibitor
0,248  0,148  Cognition disorders treatment
0,139  0,039  Photosensitizer
0,117  0,020  Glycine receptor antagonist
0,122  0,024  Adrenaline agonist
0,121  0,024  Phosphodiesterase 6D inhibitor
0,117  0,021  MAP-kinase-activated kinase 2 inhibitor
0,124  0,028  Antithrombocytopenic
0,109  0,014  CC chemokine 5 receptor agonist
0,166  0,071  Antihelmintic (Nematodes)
0,220  0,127  Prostate cancer treatment
0,126  0,034  Prolactin inhibitor
0,204  0,112  DNA damaging
0,121  0,029  NAD(P)H dehydrogenase (quinone) inhibitor
0,179  0,088  UGT1A1 substrate
0,133  0,042  NAT2 substrate
0,154  0,065  Genotoxic
0,166  0,077  UGT2B7 substrate
0,106  0,020  SULT1A2 substrate
0,149  0,064  Adenylate cyclase stimulant
0,193  0,107  Cytostatic
0,128  0,044  GABA C receptor agonist
0,196  0,113  Acute neurologic disorders treatment
0,140  0,057  MAP kinase kinase inhibitor
0,155  0,073  Antimutagenic
0,161  0,079  UGT1A4 substrate
0,150  0,069  UGT2B15 substrate
0,231  0,150  CYP3A4 substrate
0,152  0,072  Pulmonary hypertension treatment
0,102  0,024  Dopamine D1 antagonist
0,114  0,038  NMDA receptor antagonist
0,123  0,050  Protein kinase C gamma inhibitor
0,096  0,023  Phosphodiesterase VI inhibitor
0,174  0,101  Interleukin antagonist
0,098  0,026  Phenylalanine 4-hydroxylase inhibitor
0,131  0,059  Topoisomerase II inhibitor
0,235  0,163  CYP2C9 substrate
0,158  0,087  Catenin beta inhibitor
0,098  0,028  Estrogen receptor alpha antagonist
0,188  0,118  RNA-directed DNA polymerase inhibitor
0,076  0,007  Dopamine D5 agonist
0,172  0,103  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,207  0,138  5 Hydroxytryptamine uptake stimulant
0,132  0,064  Glutamate receptor antagonist
0,129  0,061  Antiviral (Papilloma)
0,214  0,147  AR expression inhibitor
0,128  0,061  Adenylate cyclase inhibitor
0,159  0,092  Antineoplastic (gastric cancer)
0,141  0,075  Lipid peroxidase inhibitor
0,078  0,012  NMDA receptor subunit 3A antagonist
0,180  0,115  VCAM1 expression inhibitor
0,114  0,049  Alpha adrenoreceptor antagonist
0,107  0,042  Protein kinase C zeta inhibitor
0,116  0,051  UGT2B1 substrate
0,115  0,051  DOPA decarboxylase inhibitor
0,183  0,119  Antineoplastic (non-small cell lung cancer)
0,181  0,117  NOS2 expression inhibitor
0,097  0,034  Na+ K+ transporting ATPase inhibitor
0,085  0,023  5 Hydroxytryptamine 2A agonist
0,185  0,124  MAP-kinase-activated kinase 5 inhibitor
0,177  0,115  5 Hydroxytryptamine 3E antagonist
0,085  0,024  Protein kinase C beta inhibitor
0,166  0,105  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,082  0,022  5 Hydroxytryptamine 6 antagonist
0,213  0,154  CTGF expression inhibitor
0,111  0,052  Chronic obstructive bronchitis treatment
0,177  0,118  Antineoplastic (cervical cancer)
0,197  0,138  Transcription factor STAT3 inhibitor
0,222  0,163  FMO1 substrate
0,182  0,124  Nitric-oxide synthase stimulant
0,145  0,087  UGT1A3 substrate
0,203  0,146  NOS3 expression inhibitor
0,128  0,071  Acetylcholinesterase inhibitor
0,136  0,080  CDC-like kinase 1 inhibitor
0,128  0,073  Tubulin antagonist
0,128  0,074  Toll-Like receptor antagonist
0,128  0,074  Liver cirrhosis treatment
0,121  0,068  Contraceptive female
0,077  0,025  Protein kinase C eta inhibitor
0,125  0,073  Antineoplastic (uterine cancer)
0,142  0,090  CF transmembrane conductance regulator agonist
0,127  0,075  NADPH oxidase inhibitor
0,140  0,090  Thrombolytic
0,162  0,112  CYP2B6 inhibitor
0,144  0,094  Uterine stimulant
0,064  0,015  Poly(ADP-ribose) polymerase inhibitor
0,125  0,076  Vanilloid 1 agonist
0,076  0,028  NMDA 2C receptor antagonist
0,070  0,022  Cyclin B2 inhibitor
0,165  0,117  Dependence treatment
0,149  0,102  UGT2B10 substrate
0,213  0,166  GST M1-1 substrate
0,082  0,036  Toll-Like receptor 7 antagonist
0,059  0,013  GABA B receptor antagonist
0,069  0,024  Phosphodiesterase II inhibitor
0,076  0,031  SULT2A1 substrate
0,110  0,065  5 Hydroxytryptamine 3A agonist
0,172  0,129  ErbB-1 antagonist
0,065  0,022  Nicotinic alpha3beta2 receptor antagonist
0,160  0,117  Anticonvulsant
0,056  0,014  Poly(ADP-ribose) polymerase 1 inhibitor
0,135  0,093  Ca2+-transporting ATPase inhibitor
0,089  0,047  Carbonic anhydrase VI inhibitor
0,134  0,092  Cholinergic
0,190  0,148  Antineoplastic (bladder cancer)
0,072  0,030  Cyclin B1 inhibitor
0,232  0,192  CYP2C19 inhibitor
0,071  0,031  Plasminogen activator inhibitor
0,053  0,014  Acid-sensing ion channel blocker
0,071  0,031  Bombesin 1 receptor agonist
0,155  0,116  Antimitotic
0,154  0,116  Antirickettsial
0,104  0,067  Ferrochelatase inhibitor
0,189  0,152  Lipoxygenase inhibitor
0,063  0,027  5 Hydroxytryptamine 7 agonist
0,066  0,030  Beta 2 adrenoreceptor agonist
0,087  0,051  D-Ala-D-Ala ligase inhibitor
0,160  0,124  Antineoplastic (glioma)
0,104  0,069  Antihelmintic (Fasciola)
0,094  0,060  Antiadrenergic
0,133  0,099  UGT2B9 substrate
0,071  0,037  Beta adrenoreceptor antagonist
0,052  0,018  Phosphodiesterase 6C inhibitor
0,062  0,029  Cyclin B inhibitor
0,057  0,024  Topoisomerase II beta inhibitor
0,069  0,036  Beta 3 adrenoreceptor antagonist
0,058  0,026  Phosphodiesterase 2A inhibitor
0,074  0,042  Alpha adrenoreceptor agonist
0,145  0,114  Neurotensin receptor agonist
0,083  0,052  Phosphodiesterase 3A inhibitor
0,224  0,193  Antipruritic, allergic
0,146  0,115  Phospholipase C inhibitor
0,090  0,060  Adrenaline antagonist
0,186  0,156  Antiischemic
0,069  0,040  Uterine relaxant
0,076  0,048  Glutamate decarboxylase inhibitor
0,165  0,138  Antiviral (Ebola)
0,064  0,037  Alpha 2 adrenoreceptor agonist
0,110  0,083  Antiseptic
0,142  0,116  Cyclin-dependent kinase 3 inhibitor
0,045  0,020  Phenylethanolamine N methyltransferase inhibitor
0,117  0,092  Antiprotozoal (Trichomonas)
0,136  0,111  Carcinogenic, group 1
0,085  0,061  Histamine N-methyltransferase inhibitor
0,056  0,032  5 Hydroxytryptamine 1B agonist
0,044  0,020  AMPA 4 receptor antagonist
0,189  0,165  Hypoxia-inducible factor 1 alpha inhibitor
0,071  0,047  I kappa B kinase 1 inhibitor
0,182  0,158  Antiviral (West Nile virus)
0,204  0,182  GST A substrate
0,134  0,111  Carcinogenic
0,132  0,110  Arachidonic acid antagonist
0,127  0,106  Antifungal (Cryptococcus)
0,030  0,009  Dopamine D1 agonist
0,090  0,070  Alpha 2d adrenoreceptor antagonist
0,090  0,070  MAP kinase kinase 1 inhibitor
0,127  0,108  Raynaud's phenomenon treatment
0,134  0,116  Interleukin 6 antagonist
0,099  0,080  5 Hydroxytryptamine antagonist
0,055  0,037  Myc inhibitor
0,112  0,094  Toll-Like receptor 9 antagonist
0,087  0,069  Breast cancer-resistant protein inhibitor
0,076  0,059  Acetylcholine nicotinic antagonist
0,074  0,057  GABA B receptor agonist
0,084  0,069  Phosphodiesterase I inhibitor
0,083  0,067  Interleukin 5 antagonist
0,195  0,180  ICAM1 expression inhibitor
0,056  0,041  Postcoital contraceptive
0,065  0,050  Check point kinase 1 inhibitor
0,068  0,053  Histidine decarboxylase inhibitor
0,146  0,131  Abortion inducer
0,121  0,108  Death-associated protein kinase 1 inhibitor
0,039  0,026  Alpha 1d adrenoreceptor agonist
0,045  0,032  Beta adrenoreceptor agonist
0,033  0,020  Estrogen-related receptor beta antagonist
0,092  0,079  Cyclin-dependent kinase 2 inhibitor
0,037  0,025  Kinesin-like protein 1 inhibitor
0,037  0,025  Kinesin antagonist
0,035  0,022  Estrogen receptor beta agonist
0,082  0,070  Granulocyte macrophage colony stimulating factor agonist
0,089  0,078  UGT2B11 substrate
0,031  0,020  Phosphodiesterase 6B inhibitor
0,121  0,110  Insulin secretagoues
0,084  0,075  Protein kinase C mu inhibitor
0,033  0,024  Protein kinase C beta I inhibitor
0,111  0,102  Skin whitener
0,129  0,120  Nitric oxide antagonist
0,025  0,017  Kainate receptor 4 antagonist
0,089  0,080  Anabolic
0,118  0,110  Aurora-C kinase inhibitor
0,152  0,144  Antihypercholesterolemic
0,246  0,238  MAP kinase 1 inhibitor
0,096  0,089  5 Hydroxytryptamine 2B antagonist
0,055  0,048  Androgen agonist
0,050  0,044  GABA receptor antagonist
0,153  0,149  Antineoplastic enhancer
0,170  0,165  Proliferative diseases treatment
0,100  0,096  Interleukin 8 antagonist
0,056  0,052  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,022  0,019  Phosphodiesterase 6H inhibitor
0,022  0,019  Phosphodiesterase 6G inhibitor
0,176  0,174  Transcription factor STAT inhibitor
0,047  0,045  GABA A receptor antagonist
0,022  0,020  Phosphodiesterase 6A inhibitor
0,101  0,099  Sphingosine 1-phosphate receptor 2 agonist
0,096  0,094  Cyclin-dependent kinase inhibitor
0,134  0,133  ATPase inhibitor
0,161  0,160  Hypoglycemic
0,116  0,115  Antiprotozoal (Coccidial)
0,181  0,180  Antileukemic
0,165  0,164  Respiratory analeptic
0,019  0,019  Alpha 2d adrenoreceptor agonist
0,048  0,048  Alcohol oxidase inhibitor
0,036  0,036  Dopamine D5 antagonist

